ITCI Stock Price & Analysis | Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies, Inc. (ITCI) Stock AnalysisSector: HealthcareMarket Cap: $14.05BView ITCI financial statements, analyst ratings, Stocklytics Score, price history, and trading signals on Stocklytics.Overview | Financials | Analyst | Prediction | Scores | Dividends